Sponsor Check › Person
Related person on Form D filings · address state as listed: MA · listed Jan 11, 2010 → Oct 21, 2026
Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: not yet · SEC enforcement last checked: not yet
Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
Not yet searched.
Sources to be searched: CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
Search queued. Results are added automatically; check back later or follow this page to be notified.
Not yet searched.
Sources to be searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Search queued. Results are added automatically; check back later or follow this page to be notified.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons are made for sponsors and sponsor groups, not individual people.
2 of 25 offerings report sales commissions totalling $1,237,368; 0 report finder's fees; 5 report proceeds to related persons totalling $4,316,487. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Oct 21, 2026 D File 021-601971 | $0 | $0 | $0 None, other than ordinary compensation and director fees. | None listed on this filing |
| EDGAR ↗ | Aug 5, 2024 D/A File 021-460347 | $0 | $0 | $1,038,035 | None listed on this filing |
| EDGAR ↗ | Mar 1, 2024 D File 021-506508 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 12, 2024 D File 021-502312 | $0 | $0 | $2 (est.) Repayment of convertible notes. | None listed on this filing |
| EDGAR ↗ | Jun 1, 2020 D File 021-368023 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 18, 2020 D File 021-367164 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 25, 2019 D File 021-354117 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 11, 2019 D File 021-348478 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 25, 2019 D File 021-342750 | $0 | $0 | $103,450 (est.) Repayment of promissory note. | None listed on this filing |
| EDGAR ↗ | Oct 25, 2018 D File 021-324311 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 14, 2017 D File 021-294749 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 1, 2016 D/A File 021-271785 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 27, 2015 D File 021-246520 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 28, 2015 D/A File 021-242788 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 16, 2015 D File 021-241858 | $0 | $0 | $675,000 (est.) The Issuer expects to pay approximately $675,000 of the gross proceeds to related persons as compensation, including benefits, over the course of one year. | None listed on this filing |
| EDGAR ↗ | Jun 25, 2014 D File 021-219828 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 6, 2014 D File 021-209333 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 20, 2013 D/A File 021-201107 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 6, 2012 D/A File 021-168953 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 31, 2011 D File 021-160578 | $434,868 | $0 | $0 | Leerink Swann LLC BrokerCheck CRD 39011 ↗ via Leerinks Swann LLC (CRD 39011 ↗) |
| EDGAR ↗ | May 31, 2011 D File 021-160580 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 10, 2010 D File 021-143283 | $0 | $0 | $0 (est.) | None listed on this filing |
| EDGAR ↗ | Apr 14, 2010 D File 021-140572 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 22, 2010 D File 021-76309 | $802,500 (est.) | $0 | $0 | U.S. Boston Capital Corporation no CRD number reported |
| EDGAR ↗ | Feb 4, 2010 D/A File 021-123566 | $0 | $0 | $2,500,000 (est.) | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
| Source | Issuer | Role | Filed | Form | Offering | Sold | Investors | Min. investment |
|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | Quiver Holdings Inc. | Director | Oct 21, 2026 | D | Indefinite similar: $2,000,000–$19,999,994 | $3,005,000 | 4 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Diceros Therapeutics, Inc. | Director | Aug 5, 2024 | D/A | $18,069,960 similar: $2,000,000–$19,999,994 | $12,609,962 | 13 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | EnClear Therapies, Inc. | Director | Mar 1, 2024 | D | $1,999,996 similar: $500,000–$7,000,000 | $718,331 | 8 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Aquacultural Research Corp | Executive Officer, Director | Jan 12, 2024 | D | $1,500,000 similar: $500,000–$7,000,000 | $1,229,169 | 17 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Diceros Therapeutics, Inc. | Director | Sep 30, 2022 | D | $16,699,979 similar: $2,000,000–$19,999,994 | $6,679,992 | 13 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | SQZ Biotechnologies Co | Director | Jun 1, 2020 | D | $70,203,000 similar: $2,000,000–$19,999,994 | $66,253,006 | 27 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | QurAlis Corp | Director | May 18, 2020 | D | $60,000,000 similar: $1,694,259–$16,000,000 | $33,222,703 | 25 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | SQZ Biotechnologies Co | Director | Nov 25, 2019 | D | Indefinite similar: $2,000,000–$19,999,994 | $71,253,215 | 48 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Continuus Pharmaceuticals, Inc. | Director | Sep 11, 2019 | D | $5,000,041 similar: $1,694,259–$16,000,000 | $5,000,041 | 20 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Aquacultural Research Corp | Director | Jun 25, 2019 | D | $977,460 similar: $500,000–$7,000,000 | $428,368 | 8 similar: 2–14 | $5,000 similar: $5,000–$50,000 |
| EDGAR ↗ | Q-State Holdings, Inc. group: Q State | Executive Officer, Director | Oct 25, 2018 | D | $66,631,545 similar: $2,000,000–$19,999,994 | $64,831,545 | 51 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Greenlight Biosciences Inc. group: Greenlight | Director | Sep 14, 2017 | D | $18,000,000 similar: $1,100,015–$10,001,163 | $9,999,995 | 10 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | SQZ Biotechnologies Co | Director | Dec 1, 2016 | D/A | $24,061,840 similar: $2,000,000–$19,999,994 | $24,061,840 | 34 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | SQZ Biotechnologies Co | Director | Oct 4, 2016 | D | $15,739,913 similar: $2,000,000–$19,999,994 | $15,739,913 | 26 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Aquacultural Research Corp | Director | Aug 27, 2015 | D | $1,626,000 similar: $500,000–$7,000,000 | $1,626,000 | 17 similar: 2–14 | $25,000 similar: $5,000–$50,000 |
| EDGAR ↗ | SQZ Biotechnologies Co | Director | Jul 28, 2015 | D/A | $5,081,019 similar: $2,000,000–$19,999,994 | $5,081,019 | 24 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | SQZ Biotechnologies Co | Director | Jun 30, 2015 | D | $5,011,019 similar: $2,000,000–$19,999,994 | $5,011,019 | 22 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Greenlight Biosciences Inc. group: Greenlight | Director | Jun 16, 2015 | D | $20,007,507 similar: $2,000,000–$19,999,994 | $20,007,507 | 7 similar: 2–16 | $91,000 similar: $10,000–$50,000 |
| EDGAR ↗ | Continuus Pharmaceuticals, Inc. | Director | Jun 25, 2014 | D | $2,600,000 similar: $1,694,259–$16,000,000 | $2,463,659 | 15 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | RAILRUNNER NA INC | Director | Jan 6, 2014 | D | $6,082,611 similar: $500,000–$7,000,000 | $6,082,611 | 10 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Greenlight Biosciences Inc. group: Greenlight | Director | Dec 20, 2013 | D/A | $8,045,815 similar: $2,000,000–$19,999,994 | $8,045,815 | 3 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Greenlight Biosciences Inc. group: Greenlight | Director | Aug 9, 2013 | D | $7,000,000 similar: $2,000,000–$19,999,994 | $7,000,000 | 2 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | AVAXIA BIOLOGICS, Inc | Director | Jan 6, 2012 | D/A | $4,460,000 similar: $829,831–$9,999,998 | $3,443,378 | 94 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | AVAXIA BIOLOGICS, Inc | Director | Nov 18, 2011 | D | $4,460,000 similar: $829,831–$9,999,998 | $2,281,339 | 48 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Radius Health, Inc. | Director Mr. Fleming is a director of the Issuer. | May 31, 2011 | D | $126,880,217 similar: $1,694,259–$16,000,000 | $126,880,217 | 36 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Radius Health, Inc. | Director Mr. Fleming is a director of the Issuer. | May 31, 2011 | D | $64,285,446 similar: $1,694,259–$16,000,000 | $64,285,446 | 18 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | Rib-X Pharmaceuticals, Inc. | Director | Jun 10, 2010 | D | $15,000,000 similar: $1,694,259–$16,000,000 | $5,500,000 | 16 similar: 1–13 | No minimum reported similar: $10,000–$55,000 |
| EDGAR ↗ | HYDROCISION INC | Director | Apr 14, 2010 | D | $700,000 similar: $2,000,000–$19,999,994 | $623,635 | 8 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | RAILRUNNER NA INC | Director | Feb 22, 2010 | D | $13,375,000 similar: $500,000–$7,000,000 | $13,375,000 | 1 similar: 2–14 | $100,000 similar: $5,000–$50,000 |
| EDGAR ↗ | MOLECULAR BIOMETRICS INC | Director | Feb 4, 2010 | D/A | $16,961,567 similar: $2,000,000–$19,999,994 | $12,755,376 | 16 similar: 2–16 | $2 similar: $10,000–$50,000 |
| EDGAR ↗ | MOLECULAR BIOMETRICS INC | Director | Jan 11, 2010 | D | $16,961,567 similar: $2,000,000–$19,999,994 | $12,500,000 | 4 similar: 2–16 | $2 similar: $10,000–$50,000 |
Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years (5 industry/exemption sets on this page); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Not linked to this profile — a second identifier (same issuer, same sponsor group) was not found. Could be the same person or a different one.
People and management entities the issuers listed as related persons on the same Form D filings as Jonathan Fleming. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period)
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when Jonathan Fleming appears on a new Form D, or when a court case or SEC action is matched to them. See plans →